borderline significancep=0.066
For overall survival, the absence of HER2 overexpression was associated with less favorable OS, with borderline significance (HR=3.67, 95%CI 0.83-16.16, p=0.066).
For overall survival, the absence of HER2 overexpression was associated with less favorable OS, with borderline significance (HR=3.67, 95%CI 0.83-16.16, p=0.066).
Despite these promising results, further confirmed by the PEGASE 07 phase 3 study 11 , highly significant toxicities leading to premature termination of another phase 2 trial (PEGASE 05 study) prevented the integration of HDC-AHSCT as a standard of care 12 .
In our series TN subtype carried the least favorable prognosis, even though the difference did not reach statistical significance which is consistent with previously known data in IBC or non-IBC patient population 17 , 20 , 21 .